SEARCH

SEARCH BY CITATION

References

  • 1
    Willcox S, Seddon M, Dunn S, et al. Measuring and reducing waiting times: a cross-national comparison of strategies. Health Aff 2007;26:107887.
  • 2
    Postl BD. Final Report of the Federal Advisor on Wait Times. Ottawa: Publications Health Canada, 2006.
  • 3
    Caro JJ. Pharmacoeconomic analyses using discrete event simulation. Pharmacoeconomics 2005;23:32332.
  • 4
    Davies HTO, Davies R. Simulating health systems: modelling problems and software solutions. Eur J Oper Res 1995;87:3544.
  • 5
    Haycox A. Pharmacoeconomics of long-acting risperidone: results and validity of cost-effectiveness models. Pharmacoeconomics 2005;23(Suppl. 1):316.
  • 6
    Jun JB, Jacobson SH, Swisher JR. Application of discrete-event simulation in health care clinics: a survey. J Oper Res Soc 1999;50:10923.
  • 7
    Brennan A, Chick SE, Davies R. A taxonomy of model structures for economic evaluation of health technologies. Health Econ 2006;15:1295310.
  • 8
    Stahl JE. Modelling methods for pharmacoeconomics and health technology assessment: an overview and guide. Pharmacoeconomics 2008;26:13148.
  • 9
    Hill R, Bagust A, Bakhai A, et al. Coronary artery stents: a rapid systematic review and economic evaluation. Health Technol Assess 2004;8:iii–iv; 1242.
  • 10
    Holmes DR Jr, Leon MB, Moses JW, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patIENTS at high risk for coronary restenosis. Circulation 2004;109:63440.
  • 11
    Jahn B, Pfeiffer KP, Theurl E. Capacity constraints and cost-effectiveness: a discrete event simulation for drug-eluting stents. Med Decis Making 2010;30:1628.
  • 12
    Banks J, Carson J, Nelson BL, Nicol D, et al. Discrete-Event System Simulation (3rd ed.). Upper Saddle River, NU: Prentice Hall, 2005.
  • 13
    Preater J. Queues in health. Health Care Manag Sci 2002;5:283.
  • 14
    Vissers JM, Bij JDVD, Kusters RJ. Towards decision support for waiting lists: an operations management view. Health Care Manag Sci 2001;4:13342.
  • 15
    Mühlberger V, Leisch F, Probst P. Reports of the Working Group Interventional Cardiology of the Austrian Society of Cardiology. Cardiac Catheter Interventions European Statistics 2004/Austria. Available at: http://iik.i-med.ac.at/files/2004/countrysum_04.pdf.
  • 16
    Bowen J, Hopkins R, He Y, et al. DES Report systematic review and cost-effectiveness analysis of drug eluting stents compared to bare metal stents for percutaneous coronary interventions in Ontario. Report No.: HTA002-0512. Hamilton, ON, Canada: Path Research Institute, December 2005. Available at: http://www.path-hta.ca/report.htm.
  • 17
    Abellán JJ, Armero C. Predicting the behaviour of the renal transplant waiting list in the País Valencià (Spain) using simulation modelling. Proceedings of the 36th Conference on Winter Simulation. Washington, DC: Winter Simulation Conference. 2004. Available at: http://portal.acm.org/citation.cfm?id=1162102#.
  • 18
    Henderson SG, Mason AJ. Estimating ambulance requirements in Aukland, New Zealand. Proceedings of the 1999 Winter Simulation Conference. New York: ACM, 1999.
  • 19
    Litva KN, Van Rijsbergen M, Boucherie RJ, Van Houdenhoven M. Managing the overflow of intensive care patients. Eur J Oper Res 2008;185:9981010.
  • 20
    Stahl JE, Roberts MS, Gazelle S. Optimizing management and financial performance of the teaching ambulatory care clinic. J Gen Intern Med 2003;18:26674.
  • 21
    Marcon E, Dexter F. Impact of surgical sequencing on post anesthesia care unit staffing. Health Care Manag Sci 2006;9:8798.
  • 22
    Shechter SM, et al. A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process. Med Decis Making 2005;25:199209.
  • 23
    Caro JJ, et al. Cost-benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator versus amiodarone. Value Health 2007;10:1322.
  • 24
    Caro J, Ward A, Moller J. Modelling the health benefits and economic implications of implanting dual-chamber vs. single-chamber ventricular pacemakers in the UK. Europace 2006;8:44955.
  • 25
    Kuhl ME, Damerdji H, Wilson JR. Estimating and simulating poisson processes with trend or asymetric cyclic effects. Proceedings of the 29th Conference on Winter Simulation. Washington, DC: IEEE Computer Society, pp. 287–295. 1997.
  • 26
    Kuhl ME, Sumant SG, Wilson JR. Simulation input modeling: a flexible automated procedure for modeling complex arrival processes. Proceedings of the 35th Conference on Winter Simulation. 2003. Available at: http://portal.acm.org/citation.cfm?id=1030818.1030874.
  • 27
    Siebert U. When should decision-analytic modeling be used in the economic evaluation of health care? Eur J Health Econ 2003;4:14350.
  • 28
    Serruys PW, Unger F, Sousa JE, et al. Comparison of coronaryartery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:111724.
  • 29
    Nelson BL. Stochastic Modeling: Analysis & Simulation. Mineola, NY: Dover Publications, 2003.
  • 30
    Serfozo RF. Stochastic models. In: HeymanDP, SobelMJ, eds. Handbooks in Operations Research and Management Science, Vol. 2. Amsterdam, The Netherlands: Elsevier Science Publisher B.V. (North-Holland), 1990.